Upon receipt, the device was interrogated, revealing the battery status bos, five charging cycles were recorded to the device memory.The header of the icd was visually inspected.The inspection revealed residues of blood inside the is-1 ra header bore and on the is-1 ra set screw thread as well as underneath the sealing plug of that set screw, indicating a blood inclusion through the is-1 ra header bore.Beside this, the analysis showed no anomalies.Especially the dimensions of the header bores were confirmed to be within the specifications.There was no indication of a material or manufacturing problem.The memory content of the device was inspected.The inspection revealed a decreased atrial pacing impedance of <200 ohm on (b)(6), 2015, confirming the clinical observation.Therefore the impedance measurement functions of the device were tested and proved to be fully functional.For this reason, it can be assumed that the decreased atrial pacing impedance resulted from the observed blood contamination of the is-1 ra header bore.However, the time of blood inclusion was not determinable.The ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be flawless and in amplitude and frequency as programmed.A fibrillation signal was applied and the device delivered a defibrillation shock as specified,documenting a correct sensing and shock delivery.In particular, the specified energy level was reached.In summary, the clinical observation most probably resulted from a blood inclusion into the is-1 ra header bore.The exact time of blood inclusion was not determinable.However, a thorough analysis of the icd, especially of the impedance measurement functions and the therapeutic functionality proved the device to be fully functional.There was no indication of a device malfunction.
|